Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia

Clinical and Vaccine Immunology

Volumn 17, Issue 5, 2010, Pages 771-777

  Su, Wen Lin ^a,b   Perng, Wann Cherng ^a,b   Huang, Ching Hui ^a   Yang, Cheng Yu ^a   Wu, Chin Pyng ^a,c   Chang, Feng Yee ^a,b   Chen, Jenn Han ^a,d,e  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Landseed Hospital   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOSTIMULATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOOD; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PNEUMONIA; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 77951991458     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00526-09     Document Type: Article

References (26)

1. Akarsu, S., A. N. Kurt, Y. Dogan, E. Yilmaz, A. Godekmerdan, and A. D. Aygun. 2005. The differential diagnostic values of cytokine levels in pleural effusions. Mediators Inflamm. 2005:2-8. (Pubitemid 40942904)
2. Al-Attiyah, R., and A. S. Mustafa. 2008. Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG. Infect. Immun. 76:4190-4198.
3. Chegou, N. N., G. F. Black, M. Kidd, P. D. van Helden, and G. Walzl. 2009. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm. Med. 9:21.
4. Conway Morris, A., K. Kefala, T. S. Wilkinson, O. L. Moncayo-Nieto, K. Dhaliwal, L. Farrell, T. S. Walsh, S. J. Mackenzie, D. G. Swann, P. J. Andrews, N. Anderson, J. R. Govan, I. F. Laurenson, H. Reid, D. J. Davidson, C. Haslett, J. M. Sallenave, and A. J. Simpson. 12 October 2009. Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia. Thorax. doi:10.1136/thx/2009.122291.
5. Daly, C., and B. J. Rollins. 2003. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity therapeutic opportunities and controversies. Microcirulation 10:247-257. (Pubitemid 39004252)
6. Drosten, C., M. Panning, and S. Kramme. 2003. Detection of Mycobacterium tuberculosis by real-time PCR using pan-mycobacterial primers and a pair of fluorescence resonance energy transfer probes specific for the M. tuberculosis complex. Clin. Chem. 49:1659-1661.
7. Ehlers, S. 1999. Immunity to tuberculosis: a delicate balance between protection and pathology. FEMS Immunol. Med. Microbiol. 23:149-158.
8. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
9. Fulton, S. A., J. V. Cross, Z. T. Toossi, and W. H. Boom. 1998. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178:1105-1114.
10. Hanna, B. A., A. Ebrahimzadeh, L. B. Elliott, M. A. Morgan, S. M. Novak, S. Rusch-Gerdes, M. Acio, D. F. Dunbar, T. M. Holmes, C. H. Rexer, C. Savthyakumar, and A. M. Vannier. 1999. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J. Clin. Microbiol. 37:748-752.
11. Huebner, R. E., M. F. Schein, and J. B. Bass, Jr. 1993. The tuberculin skin test. Clin. Infect. Dis. 17:968-975.
12. Hughes, A. J., P. Hutchinson, T. Gooding, N. J. Freezer, S. R. Holdsworth, and P. D. Johnson. 2005. Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin. Exp. Immunol. 142:132-139.
13. Jiang, J., H. Z. Shi, Q. L. Liang, S. M. Qin, and X. J. Qin. 2007. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 131:1133-1141.
14. Juffermans, N. P., A. Verbon, S. J. van Deventer, H. van Deutekom, J. T. Belisle, M. E. Ellis, P. Speelman, and T. van der Poll. 1999. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect. Immun. 67:4295-4297.
15. Keane, J. 2005. TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology 44:714-720. (Pubitemid 41487198)
16. Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740. (Pubitemid 19082507)
17. Kobashi, Y., K. Mouri, S. Yagi, Y. Obase, M. Fukuda, N. Miyashita, and M. Oka. 2008. Usefulness of the QuantiFERON RB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern. Med. 47:237-243.
18. Lalvani, A., and M. Pareek. 24 September 2009. Interferon gamma release assays: principles and practice. Enferm. Infecc. Microbiol. Clin. doi:10.1016/j.eimc.2009.05.012.
19. Mandell, L. A., R. G. Wunderink, A. Anzueto, J. G. Barglett, G. D. Campbell, N. C. Dean, S. F. Dowell, T. M. File, Jr., D. M. Musher, M. S. Niederman, A. Torres, and C. G. Whitney. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2):S27-S72.
20. Ogawa, K., H. Koga, Y. Hirakata, K. Tomono, T. Tashiro, and S. Kohno. 1997. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion. Tuber. Lung. Dis. 78:29-34.
21. Proost, P., A. Wuyts, and J. Van Damme. 1996. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J. Leukoc. Biol. 59:67-74.
22. Ribeiro-Rodrigues, R., Co. T. Resende, J. L. Johnson, F. Ribeiro, M. Palaci, R. T. Sá, E. L. Maciel, F. E. Pereira Lima, V. Dettoni, Z. Toossi, W. H. Boom, R. Dietze, J. J. Ellner, and C. S. Hirsch. 2002. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin. Diagn. Lab. Immunol. 9:818-823.
23. Ruhwald, M., M. Bjerregaard-Andersen, P. Rabna, J. Eugen-Olsen, and P. Ravn. 2009. IP-10, MCP-1, MCP-2, MCP-3 and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res. Notes 2:19.
24. Song, C. H., H. J. Kim, J. K. Park, J. H. Lim, U. O. Kim, J. S. Kim, T. H. Paik, K. J. Kim, J. W. Suhr, and E. K. Jo. 2000. Depressed interleukin-12 (IL-12) but not IL-18 production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect. Immun. 68:4477-4484.
25. Sørensen, A. L., S. Nagai, G. Houen, P. Andersen, and A. B. Andersen. 1995. Purification and characterization of a low-molecular mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63:1710-1717.
26. Wu, H. P., C. K. Chen, K. Chung, B. Y. Jiang, T. J. Yu, and D. Y. Chuang. 2009. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity. J. Formos. Med. Assoc. 108:20-27.